Anika Therapeutics, Inc. (ANIK) shareholders
Close on Nov 17, 2026Market cap $171.97MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Lawrence A. Oberman Joint filing with Trigran Investments, Inc. (11.20%), Douglas T. Granat (11.20%) and 3 more | 1,621,215 | 11.20% | 13G (passive) amendment | Sep 30, 2025 |
| Caligan Partners LP Joint filing with David Johnson (9.95%) | 1,435,130 | 9.95% | 13D (active) amendment | Jan 23, 2026 |
| David Johnson Joint filing with Caligan Partners LP (9.95%) | 1,435,130 | 9.95% | 13D (active) amendment | Nov 19, 2025 |
| BlackRock, Inc. | 963,078 | 6.80% | 13G (passive) amendment | Mar 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ANIK | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 1,449,671 | 10.83% | $21.21M | −145,222 | 0.00% |
| Caligan Partners LP | 1,435,130 | 10.72% | $21.00M | – | 0.99% |
| Morgan Stanley | 614,320 | 4.59% | $8.99M | −257,746 | 0.00% |
| Acadian Asset Management LLC | 606,544 | 4.53% | $8.87M | – | 0.01% |
| Vanguard Capital Management LLC | 572,113 | 4.27% | $8.37M | −33,664 | 0.00% |
| Aqr Capital Management LLC | 559,846 | 4.18% | $8.19M | +287,577 | 0.00% |
| Boothbay Fund Management, LLC | 529,640 | 3.96% | $7.75M | +137 | 0.10% |
| Renaissance Technologies LLC | 481,417 | 3.60% | $7.04M | −20,800 | 0.01% |
| Dimensional Fund Advisors LP | 451,095 | 3.37% | $6.60M | −7,752 | 0.00% |
| Capital Management Corp /Va | 448,474 | 3.35% | $6.56M | +753 | 0.98% |
| Deutsche Bank AG\ | 353,552 | 2.64% | $5.17M | +378 | 0.00% |
| Geode Capital Management, LLC | 331,577 | 2.48% | $4.85M | +1,526 | 0.00% |
| State Street Corp | 311,896 | 2.33% | $4.56M | −34,196 | 0.00% |
| Two Sigma Investments, LP | 252,964 | 1.89% | $3.70M | +16,844 | 0.00% |
| D. E. Shaw & Co., Inc. | 245,066 | 1.83% | $3.59M | +15,270 | 0.00% |
| Goldman Sachs Group Inc | 237,722 | 1.78% | $3.48M | +19,844 | 0.00% |
| Jacobs Levy Equity Management, Inc | 217,530 | 1.63% | $3.18M | −48,097 | 0.01% |
| Nuveen, LLC | 156,538 | 1.17% | $2.29M | +35,821 | 0.00% |
| Quantinno Capital Management LP | 155,257 | 1.16% | $2.27M | +29,431 | 0.00% |
| UBS Group AG | 145,816 | 1.09% | $2.13M | +12,742 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 133 | 12M | 91.9% | 19 / 49 | 40 / 12 | 1M | 1M |
| Q1 2026 | 130 | 12M | 92.3% | 24 / 48 | 42 / 18 | 2M | 1M |
| Q4 2025 | 126 | 12M | 92.0% | 22 / 53 | 35 / 10 | 2M | 2M |
| Q3 2025 | 117 | 12M | 91.6% | 26 / 46 | 26 / 12 | 2M | 2M |
| Q2 2025 | 103 | 13M | 95.0% | 16 / 40 | 32 / 21 | 1M | 1M |
| Q1 2025 | 108 | 13M | 94.7% | 16 / 32 | 43 / 15 | 1M | 1M |
| Q4 2024 | 109 | 13M | 93.8% | 15 / 39 | 39 / 27 | 1M | 2M |
| Q3 2024 | 122 | 13M | 98.0% | 15 / 34 | 49 / 6 | 2M | 1M |
| Q2 2024 | 114 | 13M | 99.1% | 10 / 40 | 49 / 14 | 1M | 2M |
| Q1 2024 | 120 | 15M | 100.0% | 14 / 43 | 41 / 11 | 2M | 1M |
| Q4 2023 | 117 | 14M | 100.0% | 22 / 42 | 40 / 20 | 2M | 1M |
| Q3 2023 | 116 | 13M | 97.0% | 27 / 29 | 45 / 28 | 3M | 3M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
156 funds held ANIK in Q2 2026, 51% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of ANIK | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 397,824 | 2.97% | $5.82M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 311,291 | 2.33% | $4.55M | 0.01% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 162,458 | 1.21% | $2.38M | 0.00% | Jun 30, 2026 |
| College Retirement Equities Fund - Total Global Stock Account | 142,287 | 1.06% | $2.08M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 123,749 | 0.92% | $2.39M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 104,916 | 0.78% | $1.53M | 0.01% | Jun 30, 2026 |
| Avantis U.S. Small Cap Value ETF | 101,973 | 0.76% | $1.48M | 0.01% | May 31, 2026 |
| U.S. Small Cap Value Portfolio | 86,697 | 0.65% | $1.67M | 0.01% | Jul 31, 2026 |
| Fidelity Extended Market Index Fund | 73,771 | 0.55% | $1.07M | 0.00% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 66,746 | 0.50% | $969.82K | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 64,319 | 0.48% | $934.56K | 0.01% | May 31, 2026 |
| U.S. Small Cap Portfolio | 61,098 | 0.46% | $1.18M | 0.01% | Jul 31, 2026 |
| Dimensional US Small Cap Value ETF | 56,771 | 0.42% | $1.09M | 0.01% | Jul 31, 2026 |
| U.S. Micro Cap Portfolio | 49,285 | 0.37% | $950.21K | 0.01% | Jul 31, 2026 |
| MFS Blended Research Small Cap Equity Fund | 48,172 | 0.36% | $699.94K | 0.21% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Stephen D. Griffin | President and CEO, Director | 49,742 | 0.37% | Jun 5, 2026 |
| Ian McLeod | SVP, CAO & Treasurer | 24,888 | 0.19% | Mar 23, 2026 |
| David Colleran | EVP, General Counsel, Corp Sec | 67,570 | 0.50% | Mar 17, 2026 |
| Anne Nunes | SVP, Chief Operations Officer | 21,722 | 0.16% | Mar 18, 2025 |
| Gary P. Fischetti | Director | 54,015 | 0.40% | Aug 5, 2026 |
| Joseph H. Capper | Director | 30,805 | 0.23% | Jun 23, 2026 |
| Sheryl L. Conley | Director | 52,970 | 0.40% | Jun 23, 2026 |
| John B. Henneman Iii | Director | 65,273 | 0.49% | Jun 23, 2026 |
| Stephen Richard | Director | 58,273 | 0.44% | Jun 23, 2026 |
| Cheryl R. Blanchard | Director | 282,634 | 2.11% | Mar 17, 2026 |
| William R. Jellison | Director | 23,103 | 0.17% | Jun 24, 2025 |
| Glenn R. Larsen | Director | 50,258 | 0.38% | Jun 24, 2025 |
| Susan L. N. Vogt | Director | 50,213 | 0.38% | Jun 24, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Gary P. Fischetti Director | Aug 4, 2026 | Buy | +1,000 | $20.32 | $20.32K | 54,015 |
| Gary P. Fischetti Director | Aug 3, 2026 | Buy | +1,000 | $20.75 | $20.75K | 53,015 |
| Sheryl L. Conley Director | Jun 18, 2026 | Award | +10,402 | – | – | 52,970 |
| Stephen Richard Director | Jun 18, 2026 | Award | +10,402 | – | – | 58,273 |
| Gary P. Fischetti Director | Jun 18, 2026 | Award | +10,402 | – | – | 52,015 |
| Joseph H. Capper Director | Jun 18, 2026 | Award | +10,402 | – | – | 30,805 |
| John B. Henneman Iii Director | Jun 18, 2026 | Award | +10,402 | – | – | 65,273 |
| Stephen D. Griffin President and CEO, Director | Jun 3, 2026 | Option exercise | +12,840 | – | – | 49,742 |
| Stephen D. Griffin President and CEO, Director | Jun 3, 2026 | Tax withholding | −3,769 | $14.41 | $54.31K | 45,973 |
| John B. Henneman Iii Director | May 1, 2026 | Buy | +5,000 | $14.66 | $73.30K | 54,871 |
| Stephen D. Griffin President and CEO, Director | Apr 30, 2026 | Buy | +12,200 | $12.29 | $149.94K | 36,163 |
| Cheryl R. Blanchard Director | Mar 15, 2026 | Option exercise | +25,131 | – | – | 270,892 |
| Cheryl R. Blanchard Director | Mar 15, 2026 | Tax withholding | −12,104 | $14.20 | $171.88K | 258,788 |
| Ian McLeod SVP, CAO & Treasurer | Mar 15, 2026 | Option exercise | +2,658 | – | – | 24,888 |
| Ian McLeod SVP, CAO & Treasurer | Mar 15, 2026 | Tax withholding | −781 | $14.20 | $11.09K | 24,107 |
| David Colleran EVP, General Counsel, Corp Sec | Mar 15, 2026 | Tax withholding | −1,893 | $14.20 | $26.88K | 67,570 |
| David Colleran EVP, General Counsel, Corp Sec | Mar 15, 2026 | Option exercise | +6,449 | – | – | 69,463 |
| Cheryl R. Blanchard Director | Mar 14, 2026 | Tax withholding | −14,728 | $14.20 | $209.14K | 245,761 |
| Cheryl R. Blanchard Director | Mar 14, 2026 | Award | +24,520 | – | – | 260,489 |
| Cheryl R. Blanchard Director | Mar 14, 2026 | Option exercise | +24,519 | – | – | 235,969 |
| Ian McLeod SVP, CAO & Treasurer | Mar 14, 2026 | Option exercise | +3,774 | – | – | 22,518 |
| Ian McLeod SVP, CAO & Treasurer | Mar 14, 2026 | Award | +1,161 | – | – | 23,679 |
| Ian McLeod SVP, CAO & Treasurer | Mar 14, 2026 | Tax withholding | −1,449 | $14.20 | $20.58K | 22,230 |
| David Colleran EVP, General Counsel, Corp Sec | Mar 14, 2026 | Option exercise | +9,388 | – | – | 62,488 |
| David Colleran EVP, General Counsel, Corp Sec | Mar 14, 2026 | Award | +4,694 | – | – | 67,182 |
| David Colleran EVP, General Counsel, Corp Sec | Mar 14, 2026 | Tax withholding | −4,168 | $14.20 | $59.19K | 63,014 |
| Stephen D. Griffin President and CEO, Director | Mar 14, 2026 | Award | +6,412 | – | – | 29,907 |
| Stephen D. Griffin President and CEO, Director | Mar 14, 2026 | Tax withholding | −5,944 | $14.20 | $84.40K | 23,963 |
| Stephen D. Griffin President and CEO, Director | Mar 14, 2026 | Option exercise | +12,824 | – | – | 23,495 |
| David Colleran EVP, General Counsel, Corp Sec | Mar 9, 2026 | Tax withholding | −1,919 | $14.96 | $28.71K | 53,100 |
| David Colleran EVP, General Counsel, Corp Sec | Mar 9, 2026 | Option exercise | +5,465 | – | – | 55,019 |
| Cheryl R. Blanchard Director | Mar 9, 2026 | Option exercise | +20,001 | – | – | 217,321 |
| Cheryl R. Blanchard Director | Mar 9, 2026 | Tax withholding | −5,871 | $14.96 | $87.83K | 211,450 |
| Ian McLeod SVP, CAO & Treasurer | Mar 9, 2026 | Option exercise | +2,197 | – | – | 19,383 |
| Ian McLeod SVP, CAO & Treasurer | Mar 9, 2026 | Tax withholding | −639 | $14.96 | $9.56K | 18,744 |
| Stephen Richard Director | Jun 20, 2025 | Award | +14,164 | – | – | 47,871 |
| Gary P. Fischetti Director | Jun 20, 2025 | Award | +14,164 | – | – | 41,613 |
| William R. Jellison Director | Jun 20, 2025 | Award | +14,164 | – | – | 20,403 |
| John B. Henneman Iii Director | Jun 20, 2025 | Award | +14,164 | – | – | 49,871 |
| Sheryl L. Conley Director | Jun 20, 2025 | Award | +14,164 | – | – | 42,568 |
| Joseph H. Capper Director | Jun 20, 2025 | Award | +14,164 | – | – | 20,403 |
| Susan L. N. Vogt Director | Jun 20, 2025 | Award | +14,164 | – | – | 50,213 |
| Glenn R. Larsen Director | Jun 20, 2025 | Award | +14,164 | – | – | 50,258 |
| Stephen D. Griffin EVP, CFO & COO | Jun 3, 2025 | Tax withholding | −3,769 | $11.59 | $43.68K | 9,871 |
| Stephen D. Griffin EVP, CFO & COO | Jun 3, 2025 | Option exercise | +12,840 | – | – | 13,640 |
| Anne Nunes SVP, Chief Operations Officer | Mar 17, 2025 | Option exercise | +3,637 | – | – | 21,722 |
| Anne Nunes SVP, Chief Operations Officer | Mar 17, 2025 | Tax withholding | −1,068 | $15.91 | $16.99K | 20,654 |
| David Colleran EVP, General Counsel, Corp Sec | Mar 17, 2025 | Tax withholding | −1,893 | $15.91 | $30.12K | 47,954 |
| David Colleran EVP, General Counsel, Corp Sec | Mar 17, 2025 | Option exercise | +6,448 | – | – | 49,847 |
| Cheryl R. Blanchard President, CEO, Director | Mar 17, 2025 | Tax withholding | −12,152 | $15.91 | $193.34K | 197,320 |
| Cheryl R. Blanchard President, CEO, Director | Mar 17, 2025 | Option exercise | +25,132 | – | – | 209,472 |
| Anne Nunes SVP, Chief Operations Officer | Mar 11, 2025 | Tax withholding | −752 | $16.79 | $12.63K | 18,085 |
| Anne Nunes SVP, Chief Operations Officer | Mar 11, 2025 | Option exercise | +2,561 | – | – | 18,837 |
| David Colleran EVP, General Counsel, Corp Sec | Mar 11, 2025 | Option exercise | +7,663 | – | – | 45,649 |
| David Colleran EVP, General Counsel, Corp Sec | Mar 11, 2025 | Tax withholding | −2,250 | $16.79 | $37.78K | 43,399 |
| Cheryl R. Blanchard President, CEO, Director | Mar 11, 2025 | Option exercise | +30,060 | – | – | 197,015 |
| Cheryl R. Blanchard President, CEO, Director | Mar 11, 2025 | Tax withholding | −12,675 | $16.79 | $212.81K | 184,340 |
| David Colleran EVP, General Counsel, Corp Sec | Mar 10, 2025 | Option exercise | +5,465 | – | – | 39,590 |
| David Colleran EVP, General Counsel, Corp Sec | Mar 10, 2025 | Tax withholding | −1,604 | $16.62 | $26.66K | 37,986 |
| Cheryl R. Blanchard President, CEO, Director | Mar 10, 2025 | Option exercise | +20,002 | – | – | 172,826 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Anika Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 55 shares on Sep 30, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| William R. Jellison Former Director | Aug 7, 2026 | 16,864 | $355.26K | Aug 7, 2026 | Open Market Purchase |
Congress trades
8 trades in Anika Therapeutics reported by 1 member of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Tom Malinowski NJ07 | Bought | Mar 2, 2020 | $1K–15K | Mar 5, 2021 368 days late |
| Tom Malinowski NJ07 | Bought | Feb 28, 2020 | $1K | Aug 26, 2021 545 days late |
| Tom Malinowski NJ07 | Bought | Feb 27, 2020 | $1K | Aug 26, 2021 546 days late |
| Tom Malinowski NJ07 | Bought | Feb 26, 2020 | $15K | Mar 5, 2021 373 days late |
| Tom Malinowski NJ07 | Sold (part) | Jan 28, 2020 | $1K | Aug 26, 2021 576 days late |
| Tom Malinowski NJ07 | Sold (part) | Oct 29, 2019 | $1K | Aug 26, 2021 667 days late |
| Tom Malinowski NJ07 | Bought | Aug 1, 2019 | $50K | Aug 26, 2021 756 days late |
| Tom Malinowski NJ07 | Sold (part) | Jul 29, 2019 | $1K | Aug 26, 2021 759 days late |
See a number that looks wrong?